Tvardi Therapeutics, Inc. (FRA:69C)

Tvardi Therapeutics Statistics

Total Valuation

FRA:69C has a market cap or net worth of EUR 31.55 million. The enterprise value is 386,277.

Market Cap	31.55M
Enterprise Value	386,277

Important Dates

The next estimated earnings date is Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	9.38M
Shares Outstanding	n/a
Shares Change (YoY)	+170.52%
Shares Change (QoQ)	+10.90%
Owned by Insiders (%)	16.91%
Owned by Institutions (%)	36.88%
Float	6.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.33
P/TBV Ratio	1.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.01.

Current Ratio	3.48
Quick Ratio	3.30
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -135.64% and return on invested capital (ROIC) is -105.82%.

Return on Equity (ROE)	-135.64%
Return on Assets (ROA)	-72.68%
Return on Invested Capital (ROIC)	-105.82%
Return on Capital Employed (ROCE)	-107.08%
Revenue Per Employee	n/a
Profits Per Employee	-1.68M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.17
200-Day Moving Average	n/a
Relative Strength Index (RSI)	25.48
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.54M
Pretax Income	-20.15M
Net Income	-20.15M
EBITDA	-25.46M
EBIT	-25.54M
Earnings Per Share (EPS)	-2.75

Balance Sheet

The company has 31.07 million in cash and 194,324 in debt, giving a net cash position of 30.88 million.

Cash & Cash Equivalents	31.07M
Total Debt	194,324
Net Cash	30.88M
Net Cash Per Share	n/a
Equity (Book Value)	23.75M
Book Value Per Share	2.53
Working Capital	23.36M

Cash Flow

Operating Cash Flow	-19.30M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:69C does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-170.52%
Shareholder Yield	-170.52%
Earnings Yield	-63.87%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2